. These
the symmetry-related molecule) occupies a less oc- in the direction of Glu-V1Ј, although it does not directly contact it. The V1Ј subsite is about 8 Å away from the V6Ј subsite, as judged by the distance separating the one His and three Cys residues. The Vps27p His is atypiclosest basic side chains in each subsite. cal of the FYVE domain family. In most other FYVE se-
The crystals described here were obtained both in the quences, this position is replaced by a Cys (Figure 2 One of the most remarkable properties of the FYVE motif is that so small a protein domain can form a highly specific ligand-binding pocket. How does a tiny domain (Ferguson et al., 1995) . In the IP 3 /PH domain complex, the 4-and 5-phosphates interact with a deep pocket form a specificity pocket? The structure of the basic pocket of the FYVE domain suggests an answer. The via an extensive network of charged interactions and hydrogen bonds. In contrast, the 1-phosphate is outside basic pocket is built on top of the edge of the first ␤ strand (␤1). The main chain NH of His-191 points directly the pocket and accepts a single hydrogen bond. How can we rationalize the exacting specificity of the into the pocket, providing one ligand. The consecutive His residues 190 and 191 flank the pocket. The ␤ struc-FYVE domain for PI3P to the exclusion of closely related phosphoinositides? Despite the lack of bound PI3P in ture positions these opposite to each other. Because the ␤ strand participates in the pocket edge-on, the side these crystals, the lattice-supplied anionic ligand uses similar interactions. Its binding mode suggests a reasonchains of both His residues are exposed on the same face of the molecule. Because the His side chain is able explanation for the observed stereospecificity. The basic pocket is too small to bind an inositol bis-or the shortest of the three basic amino acids, these side chains are both within charge interaction distance of a trisphosphate, so the absence of binding to PI(3,4)P 2 , PI(4,5)P 2 , PI(3,5)P 2 , and PIP 3 is not surprising. As for the single dianionic ligand. This could be either Asp-COO Ϫ , as seen in the crystals, or a phosphate group, in the singly phosphorylated phosphoinositides, there are no reports that binding of PI(5)P to FYVE domains has been case of the physiological ligand. Arg-193 is positioned two residues away. This puts enough distance between tested. The available structural and functional data are insufficient to rule out the possibility that FYVE domains its C␣ and the pocket that the guanidino group can reach with the side chain in a fully extended conformation. This could bind this scarce lipid. The spacing between the 1-and 3-phosphate subsites is incompatible with the pocket is a nearly perfect phosphate-binding site, yet it is too sterically restricted to bind the 1-phosphate of longer distance between the 1-and 4-phosphates of PI(4)P, consistent with the lack of binding of this lipid. PI3P. We therefore expect that it is the 3-phosphatebinding site.
The Trp-170, RKHHCR sequence, and Arg-220 of the PI3P-binding site are conserved throughout the FYVE The side chain of Glu-V1Ј is 9 Å from the Asp-V6Ј carboxylate. This is just slightly greater than the 7 Å domains, consistent with a common function for all FYVE domains in PI3P binding. These residues are abbetween the 1-and 3-phosphates of PI3P. We have modeled the PI3P headgroup so that the 1-phosphate sent in the rabphilin Zn restraints of Engh and Huber (1991) and the individual thermal factor restraints of Tronrud (1996) were used. The refinement was moniExperimental Procedures tored using the free R factor calculated with 5% of observed reflections (Brü nger, 1992). The refined crystal structure includes residues Protein Expression and Purification 169-229 of Vps27p, residues V1-V6 derived from the vector, and Vps27p residues 155-229 were amplified using PCR and cloned into 111 water molecules. PROCHECK (Laskowski et al., 1993) was used the BamHI and EcoRI sites of pGEX-2T (Smith and Johnson, 1988;  to gauge the stereochemical quality of the final model, which scores Amersham-Pharmacia). The vector contributes the sequence as well as expected at 1.15 Å resolution. There are no non-Gly EFIVTD at the C terminus and a glycine residue at the N terminus residues in the disallowed or generously allowed regions of the of the predicted thrombin cleavage product of the fusion protein.
Ramachandran plot. The GST-fusion protein was expressed in BL21(DE3) cells (Novagen) and batch purified from lysate using glutathione-Sepharose resin
